This correlation has been discovered in hepatocellular carcinoma (HCC), whereby c-Fos-mediated SIRT6 transcriptional activation initiates a tumor-suppressor pathway that will be explained in detail in the following section [39]. This evidence concerns the gene FOS and hepatocellular carcinoma.